Login / Signup

PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.

Bronwen E ShawKaren L SyrjalaLynn E OnstadEric J ChowMary E FlowersHeather JimK Scott BakerSarah BuckleyDiane L FaircloughMary M HorowitzStephanie J Lee
Published in: Cancer (2017)
Physical and mental symptoms and function in autologous and allogeneic HCT survivors can be adequately assessed with PROMIS-29 and PROMIS-GH. Cancer 2018;124:841-9. © 2017 American Cancer Society.
Keyphrases
  • papillary thyroid
  • patient reported outcomes
  • squamous cell
  • bone marrow
  • mental health
  • young adults
  • stem cell transplantation
  • physical activity
  • stem cells
  • cell therapy
  • mesenchymal stem cells
  • high dose